Showing results (131-140 of 169) with videos related to
Sort By:
Pageof 17
Physiological Reports|December 20, 2014
Noninvasive assessment for acute allograft rejection in a rat lung transplantation modelAyuko Takahashi, Hiroshi Hamakawa, Hiroaki Sakai, et al.Clinical Transplantation|April 23, 2002
Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantationTadashi Matsukura, Akiko Yokoi, Hiroto Egawa, et al.The Journal of Infectious Diseases|March 19, 2005
CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17Lauren Rice, Daniel Orlow, Katherine Ceonzo, et al.Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell linesSeiji Matsumoto, Shinya Kimura, Hidekazu Segawa, et al.Lung Cancer (Amsterdam, Netherlands)|January 24, 2002
Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lungTatsuo Nakagawa, Fumihiro Tanaka, Yosuke Otake, et al.Free Radical Research|September 22, 2007
Recombinant human thioredoxin-1 becomes oxidized in circulation and suppresses bleomycin-induced neutrophil recruitment in the rat airwayTakayuki Nakamura, Yuma Hoshino, Akira Yamada, et al.Plos One|October 4, 2011
Engagement of overexpressed Her2 with GEP100 induces autonomous invasive activities and provides a biomarker for metastases of lung adenocarcinomaToshi Menju, Shigeru Hashimoto, Ari Hashimoto, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 13, 2006
Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cellsTomoya Kono, Hajime Kubo, Chikashi Shimazu, et al.Lung Cancer (Amsterdam, Netherlands)|June 21, 2008
A follow-up report on a new method of segmental resection for small-sized early lung cancerToru Bando, Ryo Miyahara, Hiroaki Sakai, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancerKazumasa Takenaka, Shinya Ishikawa, Yozo Kawano, et al.Pageof 17